Staccato Loxapine Pulmonary Safety in Healthy Volunteers
| Status: | Completed |
|---|---|
| Conditions: | Healthy Studies |
| Therapuetic Areas: | Other |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 3/13/2019 |
| Start Date: | November 2008 |
| End Date: | April 2009 |
Pulmonary Safety of Repeat Doses of Staccato® Loxapine for Inhalation in Healthy Volunteers
The objective of this trial is to assess the pulmonary safety of 2 inhaled doses of Staccato
Loxapine within a day.
Loxapine within a day.
The planned study is a multiple dose, double-blind, placebo-controlled, randomized,
2-sequence, 2-period crossover study investigating pulmonary safety in healthy volunteers.
2-sequence, 2-period crossover study investigating pulmonary safety in healthy volunteers.
Inclusion Criteria:
- nonsmoker subjects in good general health with normal spirometry at screening AND
baseline
Exclusion Criteria:
- history of asthma, COPD, or any other acute or chronic pulmonary disease or
bronchodilator use
We found this trial at
1
site
Click here to add this to my saved trials
